Searched for
GLENMARK COVID DRUG
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analysts
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%
- Glenmark concludes study on COVID drug FavipiravirResults showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects like weakness, gastritis, diar...15 Sep, 2021, 02.18 PM IST
- Interim data from study supports Favipiravir's safety, effectiveness: GlenmarkThe study, commenced in July 2020, aimed to evaluate safety and efficacy of favipiravir in mild to moderate COVID-19 patients.09 Jun, 2021, 12.33 AM IST
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...23 Nov, 2020, 02.49 PM IST
- Glenmark to launch higher strength of FabiFlu for mild and moderate symptoms of Covid-19The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a...06 Aug, 2020, 04.01 PM IST
- Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...21 Jul, 2020, 12.20 PM IST
- Glenmark drops 5% as DCGI seeks clarity on Covid-19 drug, overpricing complaintsThe drug regulator also pulled up Glenmark over the pricing of the drug, after receiving a complaint from a member of Parliament.20 Jul, 2020, 11.16 AM IST
- DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFluDrug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.19 Jul, 2020, 06.17 PM IST
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...14 Jul, 2020, 10.04 PM IST
- Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75 per tabletIn a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...13 Jul, 2020, 12.38 PM IST
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...01 Jul, 2020, 10.45 PM IST
- Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...23 Jun, 2020, 09.36 PM IST
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...23 Jun, 2020, 09.24 PM IST
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...23 Jun, 2020, 09.23 PM IST
- Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.22 Jun, 2020, 03.50 PM IST
- Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...26 May, 2020, 04.19 PM IST
- Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...12 May, 2020, 01.12 PM IST
- Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...30 Apr, 2020, 03.10 PM IST
Load More
